Celltrion and LISCure Biosciences to develop unique microbiome treatment for Parkinson’s disease
LISCure Biosciences Inc., a clinical-stage biotech is developing advanced microbiome technology with accurate targets and announced a multi-year strategic R&D collaboration with Celltrion to identify novel microbiome therapy for neurodegenerative diseases like Parkinson’s disease. – Co-research and co-development of novel microbiome…
